• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化中生长激素刺激的IGF-1生成反映肝细胞功能障碍。

Growth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunction.

作者信息

Assy Nimer, Pruzansky Yosef, Gaitini Diana, Shen Orr Zila, Hochberg Ze'ev, Baruch Yaacov

机构信息

Liver Unit, Ziv Medical Center, Safed 13100, Israel.

出版信息

J Hepatol. 2008 Jul;49(1):34-42. doi: 10.1016/j.jhep.2008.02.013. Epub 2008 Mar 27.

DOI:10.1016/j.jhep.2008.02.013
PMID:18456366
Abstract

BACKGROUND/AIMS: Previous studies reported decreased serum IGF-1 levels in cirrhosis. We aimed to correlate GH-stimulated IGF-1 responses with both MELD and Child-Pugh scores and determine the impact of portal hypertension and nutrition on IGF-1 responses.

METHODS

Fifty-three patients (56+/-2 yrs) with cirrhosis were enrolled. Serum IGF-1 levels were measured by RIA before and 24h after a single injection of GH (0.06 mg/kg).

RESULTS

Compared to controls, basal IGF-1 levels were significantly decreased in patients with cirrhosis (17.3+/-6.3 vs 13.6+/-5.1, P<0.001). Increments in IGF-1 levels were significantly lower in cirrhotic patients (controls: 133% vs 49% in MELD score <10, 38% in MELD score 11-18, and 13% in MELD score 19-24, p<0.001). 37% of patients had blunted IGF-1 responses. Increments in IGF-1 levels correlated with albumin (r=0.6), portal congestive index (r=0.4), and MAMC (r=0.25). By multivariate analysis, only CP (OR 5.7) and MELD scores (OR 4.5) accurately differentiated between blunted or non-blunted IGF-1 responses and not portal hypertension (OR 0.9) or malnutrition (OR 1.35).

CONCLUSIONS

Cirrhosis is associated with low IGF-1 levels and an attenuated response to exogenous GH. These findings correlate better with the extent of hepatic dysfunction rather than the presence of portal hypertension or malnutrition.

摘要

背景/目的:既往研究报道肝硬化患者血清胰岛素样生长因子-1(IGF-1)水平降低。我们旨在将生长激素(GH)刺激后的IGF-1反应与终末期肝病模型(MELD)评分及Child-Pugh评分相关联,并确定门静脉高压和营养状况对IGF-1反应的影响。

方法

纳入53例(56±2岁)肝硬化患者。单次注射GH(0.06mg/kg)前及注射后24小时,采用放射免疫分析法(RIA)测定血清IGF-1水平。

结果

与对照组相比,肝硬化患者的基础IGF-1水平显著降低(17.3±6.3 vs 13.6±5.1,P<0.001)。肝硬化患者IGF-1水平的升高显著低于对照组(MELD评分<10者:对照组升高133%,肝硬化患者升高49%;MELD评分11 - 18者,肝硬化患者升高38%;MELD评分19 - 24者,肝硬化患者升高13%,p<0.001)。37%的患者IGF-1反应迟钝。IGF-1水平的升高与白蛋白(r = 0.6)、门静脉充血指数(r = 0.4)及上臂中部肌肉周长(MAMC,r = 0.25)相关。多因素分析显示,只有Child-Pugh评分(比值比[OR] 5.7)和MELD评分(OR 4.5)能准确区分IGF-1反应迟钝或正常,而门静脉高压(OR 0.9)和营养不良(OR 1.35)不能。

结论

肝硬化与低IGF-1水平及对外源性GH反应减弱相关。这些发现与肝功能障碍程度的相关性更好,而非与门静脉高压或营养不良的存在相关。

相似文献

1
Growth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunction.肝硬化中生长激素刺激的IGF-1生成反映肝细胞功能障碍。
J Hepatol. 2008 Jul;49(1):34-42. doi: 10.1016/j.jhep.2008.02.013. Epub 2008 Mar 27.
2
[Hepatic transit times and liver elasticity compared with meld in predicting a 1 year adverse clinical outcome of a clinically diagnosed cirrhosis].[与终末期肝病模型(MELD)相比,肝转运时间和肝脏弹性在预测临床诊断肝硬化1年不良临床结局中的作用]
Vnitr Lek. 2016 Spring;62(5):351-9.
3
Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis.酒精性和病毒相关性肝硬化男性患者下丘脑-垂体-性腺轴功能障碍及其与Child-Pugh分级的关系
Eur J Gastroenterol Hepatol. 2003 May;15(5):495-501. doi: 10.1097/01.meg.0000059115.41030.e0.
4
Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.利用多普勒肝静脉波形阻尼指数评估肝硬化门静脉高压的严重程度及对普萘洛尔的反应:一项前瞻性非随机研究
Liver Int. 2007 Oct;27(8):1103-10. doi: 10.1111/j.1478-3231.2007.01526.x.
5
Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension.门脉静脉网膜素在肝硬化患者中增加,但与门脉高压并发症无关。
Eur J Clin Invest. 2013 Sep;43(9):926-32. doi: 10.1111/eci.12122. Epub 2013 Jul 16.
6
Insulin-like growth factor I correlates with MELD and returns to normal level after liver transplantation.胰岛素样生长因子I与终末期肝病模型(MELD)评分相关,且在肝移植后恢复至正常水平。
Ann Transplant. 2013 Feb 12;18:57-62. doi: 10.12659/AOT.883819.
7
Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.血管性血友病因子水平可预测肝硬化合并门静脉高压患者的临床结局。
Gut. 2011 Aug;60(8):1133-8. doi: 10.1136/gut.2010.235689. Epub 2011 Mar 22.
8
von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.血管性血友病因子作为肝硬化患者门静脉高压、失代偿和死亡的新的无创预测因子。
Hepatology. 2012 Oct;56(4):1439-47. doi: 10.1002/hep.25806. Epub 2012 Aug 27.
9
Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.肝硬化患者不同血管床中胰岛素样生长因子(IGF)结合蛋白(IGFBP)、IGF-I和生长激素的浓度、释放及处置情况。
J Clin Endocrinol Metab. 1995 Apr;80(4):1148-57. doi: 10.1210/jcem.80.4.7536200.
10
Prognostic value of generation of growth hormone-stimulated insulin-like growth factor-I (IGF-I) and its binding protein-3 in patients with compensated and decompensated liver cirrhosis.
Dig Dis Sci. 1998 Jun;43(6):1317-21. doi: 10.1023/a:1018828412631.

引用本文的文献

1
Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortality.肝硬化中的胰岛素样生长因子-1与肝功能障碍和纤维化相关,并可预测肝脏相关死亡率。
Aliment Pharmacol Ther. 2025 Jan;61(1):88-98. doi: 10.1111/apt.18289. Epub 2024 Sep 21.
2
Association of chronic liver disease with bone diseases and muscle weakness.慢性肝病与骨骼疾病和肌肉无力的关联。
J Bone Miner Metab. 2024 Jul;42(4):399-412. doi: 10.1007/s00774-023-01488-x. Epub 2024 Feb 1.
3
The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.
Janus激酶-信号转导与转录激活因子通路在消化道肿瘤中的致癌机制。
Cell Commun Signal. 2024 Jan 25;22(1):68. doi: 10.1186/s12964-023-01421-9.
4
Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis.胰岛素样生长因子1可预测代偿期肝硬化患者的失代偿及长期预后。
Front Med (Lausanne). 2023 Jul 24;10:1233928. doi: 10.3389/fmed.2023.1233928. eCollection 2023.
5
The associations of gut microbiota, endocrine system and bone metabolism.肠道微生物群、内分泌系统与骨代谢之间的关联。
Front Microbiol. 2023 Apr 6;14:1124945. doi: 10.3389/fmicb.2023.1124945. eCollection 2023.
6
Implications of pre-transplant sarcopenia and frailty in patients with non-alcoholic steatohepatitis and alcoholic liver disease.非酒精性脂肪性肝炎和酒精性肝病患者移植前肌肉减少症和虚弱的影响
Transl Gastroenterol Hepatol. 2022 Jul 25;7:29. doi: 10.21037/tgh-20-236. eCollection 2022.
7
Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry.胰岛素样生长因子-1(IGF-1)作为心力衰竭患者心血管死亡率的预测因子:来自 T.O.S.CA. 登记处的数据。
Intern Emerg Med. 2022 Sep;17(6):1651-1660. doi: 10.1007/s11739-022-02980-4. Epub 2022 Apr 21.
8
Disruption of the circadian clock component BMAL1 elicits an endocrine adaption impacting on insulin sensitivity and liver disease.生物钟组件 BMAL1 的破坏会引起内分泌适应,影响胰岛素敏感性和肝脏疾病。
Proc Natl Acad Sci U S A. 2022 Mar 8;119(10):e2200083119. doi: 10.1073/pnas.2200083119. Epub 2022 Mar 1.
9
Cystic fibrosis related liver disease and endocrine considerations.囊性纤维化相关肝病及内分泌方面的考量
J Clin Transl Endocrinol. 2021 Dec 13;27:100283. doi: 10.1016/j.jcte.2021.100283. eCollection 2022 Mar.
10
Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver.慢性肝病的营养:印度国家肝脏研究协会共识声明
J Clin Exp Hepatol. 2021 Jan-Feb;11(1):97-143. doi: 10.1016/j.jceh.2020.09.003. Epub 2020 Oct 1.